
Telomir Pharmaceuticals
Telomere-based therapies targeting age-related diseases by enhancing DNA protection and cell renewal.
Market cap
$47.8m
Enterprise value
$48m
Share price
$1.48 TELO
Authorizing premium user...
Telomere-based therapies targeting age-related diseases by enhancing DNA protection and cell renewal.